Search Results

Biotech Bay

bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia

bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.

May 19, 2024

·

4 min read

Biotech Bay

bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day

bioLytical Laboratories Inc. proudly announces its donation of 1,200 INSTI® HIV-1/2 Antibody Tests to KFF’s Greater Than AIDS campaign in support of National HIV Testing Day, June 27.

June 27, 2024

·

3 min read

bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics and partner Coalition PLUS, a global NGO, announced that together, they have donated and distributed over 8,000 tests across 25 countries to help boost testing access worldwide.

November 22, 2023

·

4 min read

bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it has received Health Canada authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test, allowing its immediate entry into the Canadian market.

March 27, 2023

·

6 min read

bioLytical Laboratories Inc. receives WHO PQ for its iStatis COVID-19 Antigen Home Test

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced it has received its WHO PQ for its self-test, the iStatis COVID-19 Antigen Home Test, allowing its immediate entry into international markets.

October 18, 2022

·

4 min read

bioLytical Laboratories Inc. Receives its CE Mark for the iStatis COVID-19 Antigen Home Test

bioLytical Laboratories Inc. announced that it is launching a new platform, iStatis, and has received its CE Mark for immediate market entry into Europe for its iStatis COVID-19 Antigen Home Test.

March 21, 2022

·

4 min read

Policy

bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test

bioLytical Laboratories Inc. announced that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for its immediate market entry into Canada.

April 1, 2022

·

4 min read

Press Releases

Meet Gaelic Laboratories, your trusted testing and manufacturing partner

11 July 2024: Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.

July 11, 2024

·

2 min read

Deals

US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing.

March 19, 2024

·

2 min read

bioLytical Laboratories Inc. Receives Health Canada Authorization for its iStatis COVID-19 Antigen Test

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it is launching a new testing platform, iStatis, which has received Health Canada authorization for its iStatis COVID-19 Antigen Test, allowing its immediate entry into the Canadian market.

March 7, 2022

·

4 min read